Dilemmas With Rotavirus Vaccine: The Neonate and Immunocompromised

Area of Science:

• Pediatrics
• Vaccinology
• Infectious Diseases

Background:

• Rotavirus (RV) is a primary cause of severe gastroenteritis in young children globally.
• Routine childhood immunization with live-attenuated RV vaccines has led to a significant reduction in RV-related hospitalizations.
• Concerns exist regarding the safety and efficacy of RV vaccines in vulnerable populations, specifically preterm and immunocompromised infants.

Purpose of the Study:

• To review current research and consensus statements on the safety, immunogenicity, and viral shedding of rotavirus vaccines.
• To evaluate the RV vaccine's impact on preterm infants, including nosocomial infections, gastrointestinal issues, and feeding difficulties.
• To assess the RV vaccine's safety profile in immunocompromised infants, considering various conditions like HIV exposure and severe combined immunodeficiency.

Main Methods:

• Systematic review of existing research and consensus statements on rotavirus vaccine use in specific infant populations.
• Analysis of data on adverse events, immunogenicity, and viral shedding post-vaccination.
• Evaluation of safety outcomes in hospitalized preterm infants and select immunocompromised infants (e.g., HIV-exposed).

Main Results:

• Rotavirus vaccines are well-tolerated in hospitalized preterm infants, showing no significant increase in nosocomial infections, gastrointestinal complications, or feeding difficulties.
• In select immunocompromised infants, including those with HIV exposure, RV vaccine administration did not elevate adverse event rates.
• However, infants with severe combined immunodeficiency (SCID) exhibited increased rates of adverse events, as indicated by case reports.

Conclusions:

• Rotavirus vaccination is generally safe and well-tolerated in preterm and select immunocompromised infants.
• The risk of viral shedding and transmission from vaccinated neonates to household contacts is low and does not negate the vaccination benefits.
• Careful consideration and monitoring are warranted for RV vaccine administration in infants with severe combined immunodeficiency due to reported adverse events.